ProteinQure
proteinqure.com
Actively hiring
Oncology Therapeutics
Drug Discovery AI
Drug Discovery
As featured in
View 1 job
Claim pageClaim
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Total raised
$5.8M
3 rounds on record
Latest round
$1.8M
Venture round · May 2026 · 4 mo ago
Team
51-200
employees, estimated range
Hiring now
1
open roles
Backers
1
Golden Ventures
The money's age
Fresh money
4 months since the last round · hiring slowed
Momentum
50/100
in the news, fresh money, rising traction
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 27
Raised a round Venture round $1.8M
May 28, 2025
Raised a round Series A
Jul 9, 2020
Partnership ProteinQure Collaborates with AstraZeneca to Design Novel Peptide Therapeutics · proteinqure.com
Jul 25, 2019
Raised a round Seed $4M
2017
Founded
Tractionpublic signals, read monthly
Web presence
top 0.05%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | May 2026 | $1.8M | — | proteinqure.com |
| Series A | May 2025 | — | — | businesswire.com |
| Seed | Jul 2019 | $4M | — | proteinqure.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Golden Ventures Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Relation Therapeutics is a London biotechnology company founded in 2019 that applies graph machine learning to disease biology. Its…
Menten AI designs peptide therapeutics using computational protein design combined with quantum and classical optimisation. Founded in 2018…
Iambic Therapeutics combines machine learning with automated chemistry to discover small molecule drugs. Its NeuralPLexer models predict…
Genesis Molecular AI is a drug discovery company headquartered in Burlingame, California, and founded in 2019. The company combines deep…
PostEra uses machine learning for medicinal chemistry, proposing synthesis routes and analogues for drug discovery programmes. Founded in…
Proxima Bio is a frontier AI and data generation company that discovers proximity therapeutics by making protein interactions programmable…
News
The Monomers We Can't Find: Building a Map of Non-Canonical Chemical Space
You Can Buy It. Can You Find It? Written by Julie Owen, ProteinQure This is semaglutide. The peptide drug that has transformed obesity treatment by copying a naturally occurring gut hormone. Its clinical success rests on a few edits to the natural sequenc
Read more
Report
ProteinQure Receives $1.8M from FedDev Ontario to Advance AI-Powered Drug Delivery
TORONTO, Ontario, May 27, 2026 - ProteinQure Inc., a clinical-stage biotechnology company leveraging machine learning and generative AI to design precision therapeutics, announced it has received $1.8 million in funding from the Government of Canada throu
Read more
Report
ProteinQure Receives $2.5M Genome Canada Award to Advance siRNA Therapeutics for Glioblastoma
The company also appoints world-renowned neuro-oncologists Dr. Henry S. Friedman and Dr. Alexandra M. Miller to Clinical Advisory Board. TORONTO, Ontario, April 7, 2026 - ProteinQure Inc., a clinical-stage biotechnology company leveraging machine learning
Read more
Report
ProteinQure Reports Broad Brain Distribution of Peptide-siRNA Conjugates in Non-Human Primates
TORONTO, Ontario, October 15, 2025 - ProteinQure announced new preclinical results today, demonstrating efficient delivery of small interfering RNA (siRNA) to the central nervous system (CNS) in non-human primates. Using intrathecal administration of prop
Read more
Report
ProteinQure Announces First Patient Dosed in Phase I Clinical Trial of PQ203 in Advanced Metastatic Cancer
TORONTO, Ontario, September 17, 2025 - ProteinQure Inc., a Toronto-based biotech company pioneering computational peptide drug discovery, today announced the successful dosing of the first patient in its Phase I clinical trial evaluating PQ203 - a novel,
Read more
Report
ProteinQure Receives Regulatory Clearance to Initiate Phase I Trial for PQ203 in the U.S. and Canada; Granted FDA Fast Track Designation
TORONTO, Ontario, August 7, 2025 - ProteinQure Inc., a leader in computational protein drug discovery, today announced it has received regulatory clearance from both the U.S. Food and Drug Administration (FDA) and Health Canada to initiate a Phase I clini
Read more
Report
ProteinQure Receives Regulatory Clearance to Initiate Phase I Trial for PQ203 in the U.S. and Canada; Granted FDA Fast Track Designation
Read more
Report
Series A financing at Proteinqure to advance peptide-drug conjugate into clinic for TNBC
Proteinqure Inc. has closed an $11 million series A financing round to support the initiation of the company's first clinical trial for PQ-203, a first-in-class peptide-drug conjugate for triple-negative breast cancer (TNBC). The funds will also be used t
Read more
Report
Show more news
Tech stack
Technologies named in job postings at ProteinQure over the last 12 months, by layer, with the share of postings for each.
Technologies in use
4
Postings analysed
1
Stack modernity
85/100
Languages
Python
Cloud & platforms
Linux
Kubernetes
Practices & domains
Machine Learning
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$106k
Typical range
$106k
Open positions
1
1
Jobs
Middle
100%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Middle | 1 | $106k | $106k |
Highest paying role
Research Software Engineer
$106k
Normalized to USD per year
Growth
Hiring Momentum
34/100
Slowing
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~4 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Backend
100% ▲
Activity Timeline
Added Machine Learning to stack
Sep 2026
Added Linux to stack
Sep 2026
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Toronto
Toronto
Canada
HQ
ProteinQure Headquarters
1 open roles 1 posted in 90 days 100% engineering 50-200 est. staff $106k Avg Salary
hires for Backend
108 College St, Suite 580, , Toronto, ON M5G 0C6 Canada
Jobs
$85k – $106k per year • In office • Full-Time • 3+ years exp • Toronto
Python
Machine Learning
DevOps
Kubernetes
Linux
Apply